197 related articles for article (PubMed ID: 18358785)
1. Identification of novel IGRP epitopes targeted in type 1 diabetes patients.
Jarchum I; Nichol L; Trucco M; Santamaria P; DiLorenzo TP
Clin Immunol; 2008 Jun; 127(3):359-65. PubMed ID: 18358785
[TBL] [Abstract][Full Text] [Related]
2. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
[TBL] [Abstract][Full Text] [Related]
3. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
[TBL] [Abstract][Full Text] [Related]
4. Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.
Unger WW; Pearson T; Abreu JR; Laban S; van der Slik AR; der Kracht SM; Kester MG; Serreze DV; Shultz LD; Griffioen M; Drijfhout JW; Greiner DL; Roep BO
PLoS One; 2012; 7(11):e49213. PubMed ID: 23155466
[TBL] [Abstract][Full Text] [Related]
5. Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach.
Niens M; Grier AE; Marron M; Kay TW; Greiner DL; Serreze DV
Diabetes; 2011 Apr; 60(4):1229-36. PubMed ID: 21346176
[TBL] [Abstract][Full Text] [Related]
6. Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects.
Yang J; Danke NA; Berger D; Reichstetter S; Reijonen H; Greenbaum C; Pihoker C; James EA; Kwok WW
J Immunol; 2006 Mar; 176(5):2781-9. PubMed ID: 16493034
[TBL] [Abstract][Full Text] [Related]
7. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
[TBL] [Abstract][Full Text] [Related]
8. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.
Enée E; Martinuzzi E; Blancou P; Bach JM; Mallone R; van Endert P
J Immunol; 2008 Apr; 180(8):5430-8. PubMed ID: 18390725
[TBL] [Abstract][Full Text] [Related]
9. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
Unger WW; Pinkse GG; Mulder-van der Kracht S; van der Slik AR; Kester MG; Ossendorp F; Drijfhout JW; Serreze DV; Roep BO
Ann N Y Acad Sci; 2007 Apr; 1103():192-5. PubMed ID: 17376840
[TBL] [Abstract][Full Text] [Related]
10. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
[TBL] [Abstract][Full Text] [Related]
11. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
12. Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.
Coppieters KT; Amirian N; von Herrath MG
Clin Exp Immunol; 2011 Aug; 165(2):155-62. PubMed ID: 21605113
[TBL] [Abstract][Full Text] [Related]
13. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
14. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation.
Wang J; Tsai S; Shameli A; Yamanouchi J; Alkemade G; Santamaria P
Proc Natl Acad Sci U S A; 2010 May; 107(20):9317-22. PubMed ID: 20439719
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.
Velthuis JH; Unger WW; Abreu JR; Duinkerken G; Franken K; Peakman M; Bakker AH; Reker-Hadrup S; Keymeulen B; Drijfhout JW; Schumacher TN; Roep BO
Diabetes; 2010 Jul; 59(7):1721-30. PubMed ID: 20357361
[TBL] [Abstract][Full Text] [Related]
16. IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse.
Fuchs YF; Adler K; Lindner A; Karasinsky A; Wilhelm C; Weigelt M; Balke H; Förtsch K; Mortler-Hildebrandt LF; Harlan DM; Pechhold K; Ziegler AG; Bonifacio E
Clin Exp Immunol; 2014 May; 176(2):199-206. PubMed ID: 24387268
[TBL] [Abstract][Full Text] [Related]
17. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.
Vincent BG; Young EF; Buntzman AS; Stevens R; Kepler TB; Tisch RM; Frelinger JA; Hess PR
J Immunol; 2010 Apr; 184(8):4196-204. PubMed ID: 20220085
[TBL] [Abstract][Full Text] [Related]
18. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
19. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
Wong CP; Li L; Frelinger JA; Tisch R
J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
[TBL] [Abstract][Full Text] [Related]
20. Fulminant type 1 diabetes patients display high frequencies of IGRP-specific type 1 CD8
Chujo D; Kawabe A; Matsushita M; Tsutsumi C; Haseda F; Imagawa A; Hanafusa T; Ueki K; Kajio H; Yagi K; Tobe K; Shimoda M
Clin Immunol; 2021 Dec; 233():108893. PubMed ID: 34808330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
